Patents by Inventor Angus MacLeod

Angus MacLeod has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20070281943
    Abstract: Novel imidazo[1,2-a]pyrazine compounds are disclosed that have a formula represented by the following: The compounds may be prepared as pharmaceutical compositions, and may be used for the prevention and treatment of a variety of conditions in mammals including humans, including by way of non-limiting example, arthritis, inflammation, and others.
    Type: Application
    Filed: May 11, 2007
    Publication date: December 6, 2007
    Inventors: Martin James Andrews, Paul Edwards, Reginald Christophe Brys, Philip Huxley, Wolfgang Schmidt, Veronique Birault, Mark Chambers, Clifford Harris, Angus Macleod, Kim Hirst, Juha Clase, Gregory Bar
  • Publication number: 20070203205
    Abstract: Compounds of formula I: are potent and selective antagonists of the human 5-HT2A receptor, and hence useful in treatment of a variety of adverse conditions of the CNS.
    Type: Application
    Filed: April 27, 2007
    Publication date: August 30, 2007
    Inventors: Jose Castro Pineiro, Laura Cooper, Myra Gilligan, Alexander Humphries, Peter Hunt, Tamara Ladduwahetty, Angus MacLeod, Kevin Merchant, Monique Van Niel, Kevin Wilson
  • Publication number: 20060264474
    Abstract: The compounds of formula (I): inhibit gamma-secretase and hence are of utility in the treatment or prevention of Alzheimer's disease.
    Type: Application
    Filed: April 1, 2004
    Publication date: November 23, 2006
    Inventors: Michela Bettati, Mark Chambers, Peter Hunt, Philip Jones, Angus MacLeod, Helen Szekeres, Martin Teall
  • Publication number: 20060235021
    Abstract: A class of 4-phenylpyridazine derivatives of Formula (I), being selective ligands for GABAA receptors, in particular having high affinity for the ?2 and/or ?3 and or ?5 subunit thereof, are accordingly of benefit in the treatment and/or prevention of adverse conditions of the central nervous system, including anxiety, convulsions and cognitive disorders.
    Type: Application
    Filed: August 4, 2003
    Publication date: October 19, 2006
    Inventors: Wesley Blackaby, Peter Blurton, Frank Burkamp, Stephen Fletcher, Andrew Jennings, Richard Lewis, Angus Macleod, Leslie Street, Steve Thomas, Monique Van Niel, Kevin Wilson
  • Publication number: 20060148809
    Abstract: A class of pyridazine derivatives, substituted in the 4-position by an optionally substituted heteroaromatic ring, being selective ligands for GABAA receptors, in particular having high affinity for the ?2 and/or ?3 and/or ?5 subunit thereof, are accordingly of benefit in the treatment and/or prevention of adverse conditions of the central nervous system, including anxiety, convulsions and cognitive disorders.
    Type: Application
    Filed: August 4, 2003
    Publication date: July 6, 2006
    Inventors: Stephen Fletcher, Angus Macleod, Monique Van Niel, Kevin Wilson
  • Publication number: 20060089348
    Abstract: The present invention discloses a compound of formula (I): wherein: R1 is an aryl or heteroaryl ring; R2 is hydroxy, C1-6 alkoxy, C1-6 alkyl, amino, NR?R? or C1-6 alkyl-NR?R? where R? and R? are independently chosen from hydrogen and C1-4 alkyl and where R? and R?, together with the nitrogen atom to which they are attached, form a saturated nitrogen-containing 3-7 membered heterocycle optionally containing a further nitrogen atom and optionally substituted by NR?R? as defined above or R2 is C1-6 alkoxy substituted by NR?R? as defined above; R3 is hydrogen or C1-6 alkyl; R4 is hydrogen, C1-8 alkyl, C2-8 alkenyl, C2-8 alkynyl, C3-8 cycloalkyl, aryl or aryl C1-6 alkyl; R5 is hydrogen, C1-8 alkyl, C2-8 alkenyl, C2-8 alkynyl, C3-8 cycloalkyl, aryl, aryl C1-6 alkyl or C1-6 alkoxycarbonyl; or R4 and R5, together with the nitrogen atom to which they are attached, form a C3-C10 mono- or bicyclic saturated ring; X and Y are independently chosen from hydrogen, hydroxy, nitro, amino, cyano, CF3, halogen and C1-4 alkyl; o
    Type: Application
    Filed: February 3, 2004
    Publication date: April 27, 2006
    Inventors: Mark Chambers, Philip Jones, Angus MacLeod
  • Publication number: 20060052445
    Abstract: Compounds of formula I: are potent and selective antagonists of the human 5-HT2A receptor, and hence useful in treatment of a variety of adverse conditions of the CNS.
    Type: Application
    Filed: August 26, 2005
    Publication date: March 9, 2006
    Inventors: Jose Castro Pineiro, Laura Cooper, Myra Gilligan, Alexander Humphries, Peter Hunt, Tamara Ladduwahetty, Angus MacLeod, Kevin Merchant, Monique Van Niel, Kevin Wilson
  • Publication number: 20050101586
    Abstract: Compounds of formula I: are antagonists of the human 5-HT2A receptor, and hence useful in treatment or prevention of a variety of neurological conditions.
    Type: Application
    Filed: November 9, 2004
    Publication date: May 12, 2005
    Inventors: Mark Chambers, Neil Curtis, Angus MacLeod, Robert Maxey, Helen Szekeres
  • Patent number: 5991488
    Abstract: A conventional SPR spectroscopic device, consisting of a metallic film used with a prism to provide a surface plasmon wave, is modified by coating the film with a dielectric layer. According to one aspect of the invention, such additional layer of dielectric material functions as an optical amplifier that produces an increased sensitivity and enhanced spectroscopic capabilities in SPR. According to another aspect of the invention, the added dielectric layer can be used as a matrix for adsorbing and immobilizing the sensing materials in sensor applications. Furthermore, the dielectric layer provides a shield for both mechanical and chemical protection of the metal layer, thereby preventing the rapid deterioration that commonly accompanies such detectors. In its simplest embodiment, the invention includes only one dielectric layer; in other embodiments, a variety of multi-layer configurations may be implemented for different purposes with diverse dielectric materials.
    Type: Grant
    Filed: November 7, 1997
    Date of Patent: November 23, 1999
    Assignee: The Arizona Board of Regents on behalf of the University of Arizona
    Inventors: Zdzislaw Salamon, Gordon Tollin, H. Angus MacLeod
  • Patent number: 5521702
    Abstract: A method for the formation of a biocompatible film composed of a self-assembled bilayer membrane deposited on a planar surface. This bilayer membrane is capable of immobilizing materials to be analyzed in an environment very similar to their native state. Materials so immobilized may be subject to any of a number of analytical techniques.
    Type: Grant
    Filed: June 14, 1994
    Date of Patent: May 28, 1996
    Inventors: Zdzislaw Salamon, Richard A. Schmidt, Gordon Tollin, H. Angus Macleod